Literature DB >> 345861

Can dopamine beta-hydroxylase levels predict adverse reactions to disulfiram?

J A Ewing, B A Rouse, R A Mueller, D Silver.   

Abstract

Disulfiram had more pronounced sedative effects on healthy normal subjects with low levels of plasma dopamine-beta-hydroxylase (DBH) than it did on subjects with higher levels. It is suggested that DBH levels might provide a means of predicting increased susceptibility to disulfiram side effects.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 345861     DOI: 10.1111/j.1530-0277.1978.tb04701.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  3 in total

1.  Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.

Authors:  Brooke N Bourdélat-Parks; George M Anderson; Zoe R Donaldson; Jay M Weiss; Robert W Bonsall; Milburn S Emery; L Cameron Liles; David Weinshenker
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

2.  Posterior Reversible Encephalopathy Syndrome Instigated by Off-Label Disulfiram Use for Metastatic Melanoma.

Authors:  David R Beam; Jennifer M Knight
Journal:  Psychosomatics       Date:  2019-09-17       Impact factor: 2.386

3.  Chronic inhibition of dopamine β-hydroxylase facilitates behavioral responses to cocaine in mice.

Authors:  Meriem Gaval-Cruz; Larry Cameron Liles; Paul Michael Iuvone; David Weinshenker
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.